The Differential Effects of 3 Different Immunosuppressive
NCT00729248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2013-08-28
Summary
The study is a laboratory investigation comparing the regulatory effects of different immunosuppressive therapies in an in vitro human MLR assay of selecting specific immunosuppressive therapy to promote a regulatory profile and determining possibly newer accepted dosing and drug concentrations for agents most associated with this regulatory profile.
Conditions
- Immunosuppression
- Kidney Transplantation
Sponsors & Collaborators
-
Astellas Pharma US, Inc.
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Lorenzo Gallon, MD · Northwestern University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2009-07-31
- Completion
- 2010-01-31
Countries
- United States
Study Locations
More Related Trials
-
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
NCT01363752 ·Status: COMPLETED ·Phase: PHASE4
-
MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients
NCT00231764 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys
NCT00321113 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection
NCT00133172 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients
NCT00282243 ·Status: COMPLETED ·Phase: PHASE2
-
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
NCT00105235 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients
NCT00261820 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients
NCT00282568 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients
NCT00866879 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
NCT01517984 ·Status: TERMINATED ·Phase: PHASE2
-
To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients
NCT02723591 ·Status: COMPLETED ·Phase: PHASE4
-
Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant
NCT00148252 ·Status: TERMINATED ·Phase: PHASE4
-
Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens
NCT01653847 ·Status: COMPLETED ·Phase: NA
-
Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients
NCT00284934 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Sirolimus and Azathioprine in Lung Transplantation
NCT00321906 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation
NCT00717379 ·Status: COMPLETED ·Phase: PHASE4
-
SRL (Sirolimus) Withdrawal
NCT02062944 ·Status: COMPLETED ·Phase: NA
-
Calcineurin Free Immunosuppression in Renal Transplant Recipients
NCT00812123 ·Status: COMPLETED ·Phase: PHASE4
-
Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation
NCT00724022 ·Status: COMPLETED ·Phase: PHASE4
-
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
NCT00078559 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
NCT00275535 ·Status: COMPLETED ·Phase: PHASE4
-
Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection
NCT00885820 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients
NCT00266123 ·Status: COMPLETED ·Phase: PHASE4
-
Tacrolimus Adjustment by NFAT-related Gene Expression in Lung Allograft Recipients.
NCT02278952 ·Status: COMPLETED
-
Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
NCT00176059 ·Status: COMPLETED ·Phase: EARLY_PHASE1